Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

by Team Small News | May 29, 2025 | Pharma, Zydus

Zydus Lifesciences Ltd. has announced that its experimental drug, Usnoflast, has been granted Fast Track Designation by the US Food and Drug Administration (US FDA) for the treatment of amyotrophic lateral sclerosis (ALS). This designation is given to drugs that treat...
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

Zydus Lifesciences Receives US FDA Approval for Generic Version of Absorica, Used to Treat Severe Acne

by Team Small News | May 24, 2025 | Pharma, Zydus

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to launch its isotretinoin capsules in six different strengths. The approval allows the company to produce generic versions of Absorica, a prescription treatment for severe...
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus

The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

Today’s Earnings Schedule: Q4 Results from Hindalco, Dixon Tech, Zydus Life, and Torrent Pharma Released – Expert Earnings Projections

by Team Small News | May 20, 2025 | Pharma, Torrent Pharma, Zydus

Several Indian companies are set to announce their fourth-quarter results on Tuesday, including Hindalco Industries Ltd., Dixon Technologies (India) Ltd., Zydus Lifesciences Ltd., and Torrent Pharmaceuticals Ltd. According to consensus analysts’ estimates...
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

Gujarat’s Vyara Civil Hospital shift to PPP model Spells Agony for Tribals and Patients

by Team Small News | May 19, 2025 | Pharma, Torrent Pharma, Zydus

In 2020, the NITI Aayog recommended that state governments hand over the management of public hospitals to private players. However, the Gujarat government had already taken this step in 2009, when it privatized the Bhuj Civil Hospital, which was rebuilt after the...
Zydus receives US FDA’s fast track designation for its ALS treatment drug, Unsoflast.

USFDA approves Zydus Lifesciences’ generic version of a cholesterol-lowering medication.

by Team Small News | May 5, 2025 | Pharma, Zydus

Zydus Lifesciences has received approval from the US Food and Drug Administration (USFDA) for its generic version of a cholesterol-lowering drug. The company announced that it has received tentative approval for its generic version of Pitavastatin Calcium Tablets,...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress